Meyka AI API is live for developers.Start building.
Advertisement
Hypera S.A.

Hypera S.A. (HYPMY) Stock Overview

Explore Hypera S.A.’s financial performance, market position, analyst ratings, and future outlook.

HYPMYPNK
HealthcareDrug Manufacturers - Specialty & Generic
$4.20
$0.05(1.18%)
U.S. Market opens in 18h 47m
Advertisement

Hypera S.A. (HYPMY)

Meyka AI Score

Z

Key Financials

Market Cap3B
P/E Ratio8.19
EPS (TTM)$0.52
ROE0.13%
Fundamental Analysis

AI Price Forecasts

1 Month$5.02
3 Months$5.67
1 Year Target$4.57

HYPMY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Hypera S.A. (HYPMY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 30.62, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $4.57.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 8.19 and a market capitalization of 3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-1.18%
5-Day Change
-3.45%
1-Month Change
-12.68%
3-Month Change
1.45%
6-Month Change
-10.45%
Year-to-Date (YTD) Change
1.45%
1-Year Change
-10.06%
3-Year Change
-51.28%
5-Year Change
-43.93%
All-Time (Max) Change
-68.96%

Contact Information

55 11 3627 4206
Av. Magalhães de Castro, 4800, São Paulo, SP, 05676-120

Company Facts

10,481 Employees
IPO DateOct 15, 2010
CountryBR
Actively Trading

Frequently Asked Questions